Alison Reedy PhD
About Alison Reedy PhD
Alison Reedy, PhD, is a Clinical Scientist at Bristol Myers Squibb with extensive experience in biomedical engineering and clinical research.
Current Role at Bristol Myers Squibb
Alison Reedy PhD is currently employed as a Clinical Scientist at Bristol Myers Squibb. In this role, she is engaged in clinical research and development, focusing on discovering, developing, and delivering transformational medicines. Her work contributes to the advancement of scientific pursuits within the biopharmaceutical field.
Previous Experience at Sarah Cannon
Before joining Bristol Myers Squibb, Alison Reedy PhD worked at Sarah Cannon in the Greater Nashville Area, TN. From 2017 to 2020, she held the position of Clinical Scientist, and from 2017 to 2018, she served as a Clinical Analyst. During her tenure, she contributed to early-phase oncology and late-phase cardiovascular research, bringing her expertise in organizing and leading multidisciplinary teams.
Research Scientist at Cresilon, Inc.
From 2015 to 2016, Alison Reedy PhD was a Research Scientist at Cresilon, Inc. (formerly Suneris) in Brooklyn, NY. In this role, she focused on the development of innovative therapies and technologies designed to improve patient outcomes. Her work included extensive research in areas such as thromboprophylaxis, anticoagulation, and fibrin sealants.
Academic and Research Background
Alison Reedy PhD has a strong academic and research background in Biomedical Engineering. She obtained her Ph.D. from Georgia Institute of Technology, where she also served as a Graduate Research Assistant from 2010 to 2015. Additionally, she was an IGERT Stem Cell Biomanufacturing Trainee with the National Science Foundation. She holds a Bachelor of Science in Engineering (B.S.E) in Biomedical Engineering from Tulane University. Her extensive background supports her expertise in stem cells, tissue engineering, biomaterials, wound healing, and regenerative medicine.
MBA Education at Belmont University
Alison Reedy PhD expanded her expertise by pursuing a Master of Business Administration (MBA) in Healthcare at Belmont University's Jack C. Massey Graduate School of Business, from 2020 to 2022. This additional qualification complements her scientific and clinical expertise, equipping her with enhanced skills in business administration relevant to the healthcare industry.